Topic

Humana

A collection of 1100 issues

How to Get Pemazyre (pemigatinib) Covered by Humana in North Carolina: Complete Guide to Prior Authorization, Appeals, and Approval

Answer Box: Fastest Path to Pemazyre Coverage Pemazyre (pemigatinib) requires prior authorization from Humana in North Carolina. You'll need documented FGFR2 fusion/rearrangement testing, baseline ophthalmologic monitoring plan, and proof of prior systemic therapy failure. Submit complete documentation through Humana's provider portal for 72-hour standard review.
6 min read

How to Renew Alecensa (alectinib) Coverage with Humana in Virginia: Timeline, Documentation, and Appeals Process

Answer Box: Renewing Alecensa (alectinib) with Humana in Virginia Renewal timing: Start 30-60 days before your current authorization expires. Required documents: Updated oncologist letter showing stable disease/response, recent imaging, liver function tests, and continued ALK-positive status confirmation. Timeline: Humana provides decisions within 72 hours (24 hours if expedited). First
5 min read

Work With Your Doctor to Get Orfadin (Nitisinone) Covered by Humana in Illinois: Complete Provider Partnership Guide

Answer Box: Getting Orfadin (Nitisinone) Covered by Humana in Illinois Fast Track to Approval: Humana requires prior authorization for Orfadin (nitisinone) with decisions within 72 hours. Your doctor must submit biochemical proof of hereditary tyrosinemia type 1 (elevated succinylacetone levels), genetic testing results when available, and a dietary management plan
5 min read

Work With Your Doctor to Get Cresemba (Isavuconazole) Approved by Humana in Michigan: Complete Provider Collaboration Guide

Answer Box: Getting Cresemba Approved by Humana in Michigan To get Cresemba (isavuconazole) covered by Humana in Michigan, you'll need prior authorization with infectious disease specialist involvement and documented failure/intolerance of first-line antifungals like voriconazole. Your doctor must submit clinical evidence including culture results, imaging, and detailed
6 min read